Skip to main content

Table 3 Anti-arrhythmic therapy received from initiation to termination of supraventricular tachycardia

From: Rediscover the predictive capacity of B-type natriuretic peptide applied to neonatal supraventricular tachycardia

Anti-arrhythmic therapy

Total number of the

patients (N = 43)

SVT with AHF

(N = 17)

SVT without AHF

(N = 26)

Vagal maneuver

10

2

8

Adenosine

6

1

4

Digitalis

6

2

5

Esmolol

1

0

1

Adenosine + digitalis

9

5

4

Digitalis + esmolol

2

0

2

Adenosine + digitalis + esmolol

1

0

1

DC cardioversion

1

1

0

Adenosine + DC cardioversion

2

2

0

Digitalis + propafenone

1

0

1

Adenosine + digitalis + amiodarone

2

2

0

Esmolol + amiodarone

1

1

0

Adenosine + digitalis + propafenone + DC cardioversion

1

1

0

  1. Vagal maneuver was used in all objects, only valid terminations listed separately on the first line; +: used to represent sequential links; SVT: paroxysmalsupraventricular tachycardia; AHF: acute heart failure